Search Results - "Agbana, Preye"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Ternary Polypeptide Nanoparticles with Improved Encapsulation, Sustained Release, and Enhanced In Vitro Efficacy of Carfilzomib by Agbana, Preye, Lee, Min Jae, Rychahou, Piotr, Kim, Kyung-Bo, Bae, Younsoo

    Published in Pharmaceutical research (01-11-2020)
    “…Purpose To develop a new nanoparticle formulation for a proteasome inhibitor Carfilzomib (CFZ) to improve its stability and efficacy for future in vivo…”
    Get full text
    Journal Article
  2. 2

    Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized by Polycationic Complexation by Agbana, Preye, Park, Ji Eun, Rychahou, Piotr, Kim, Kyung-Bo, Bae, Younsoo

    Published in Journal of pharmaceutical sciences (01-03-2024)
    “…Carfilzomib (CFZ) is a second-generation proteasome inhibitor showing great efficacy in multiple myeloma treatment, yet its clinical applications for other…”
    Get more information
    Journal Article
  3. 3

    Effects of Organic Acids on Drug Release From Ternary Polypeptide Nanoparticles Entrapping Carfilzomib by Jackson, Sharonda, Agbana, Preye, Kim, Kyung-Bo, Bae, Younsoo

    Published in Journal of pharmaceutical sciences (01-04-2022)
    “…Carfilzomib (CFZ) is an FDA-approved proteasome inhibitor with antineoplastic properties against various cancers, yet its short blood retention time after…”
    Get more information
    Journal Article
  4. 4

    Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration by Kenneally, Allison M, Agbana, Preye, Gardner, Brian, Bae, Younsoo, Mitchell, Trenika, Beckman, Elizabeth J

    Published in American journal of health-system pharmacy (24-01-2023)
    “…The purpose of this study is to evaluate calcium chloride (CaCl) compatibility with commercially available and extemporaneously compounded milrinone,…”
    Get full text
    Journal Article